LAVA Therapeutics to Present Corporate Overview at 40th Annual J.P. Morgan Healthcare Conference
December 20, 2021 07:00 ET
|
LAVA Therapeutics N.V.
UTRECHT, The Netherlands and PHILADELPHIA, Dec. 20, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage biotechnology company focused on developing its proprietary...
Bayhealth Collaborates with Syapse, Bringing Data-Driven Approach to Oncology Care
December 15, 2021 10:00 ET
|
Syapse
SAN FRANCISCO and DOVER, Del., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing...
Florida Cancer Specialists & Research Institute Celebrates Opening of New State-of-the-Art Cancer Center in Bradenton
November 18, 2021 17:17 ET
|
Florida Cancer Specialists & Research Institute
Bradenton, Fla, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute (FCS) held a ribbon-cutting ceremony Wednesday, to mark the opening of its new state-of-the-art...
LAVA Therapeutics Provides Business Update and Reports Third Quarter Financial Results
November 15, 2021 07:00 ET
|
LAVA Therapeutics N.V.
LAVA-051 Phase 1/2a trial actively enrolling in hematological malignancies on track to report initial data in H1 2022LAVA-1207 Phase 1/2a trial in metastatic castrate resistant prostate cancer on...
LAVA Therapeutics and The Antibody Society Present Emerging Cancer Therapies Virtual Symposium
November 11, 2021 10:08 ET
|
LAVA Therapeutics N.V.
UTRECHT, The Netherlands and PHILADELPHIA and FRAMINGHAM, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage biotechnology company, today announced that...
LAVA Therapeutics Expands Management Team with Three Key Appointments
November 09, 2021 06:30 ET
|
LAVA Therapeutics N.V.
UTRECHT, The Netherlands and PHILADELPHIA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage biotechnology company focused on developing its proprietary...
LAVA Therapeutics to Participate in the 12th Annual Jefferies London Healthcare Conference
November 04, 2021 07:00 ET
|
LAVA Therapeutics N.V.
UTRECHT, The Netherlands and PHILADELPHIA, Nov. 04, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage biotechnology company focused on developing its proprietary...
Stingthera, Inc. Announces Clinical Collaboration with Merck to Evaluate SNX281 in Combination With KEYTRUDA® (pembrolizumab) in Certain Patients with Advanced Solid Tumors and Lymphoma
November 03, 2021 06:45 ET
|
Stingthera, Inc.
BOSTON, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Stingthera, Inc. today announced it has entered into a clinical trial collaboration agreement with Merck (known as MSD outside the United States and Canada)...
LAVA Therapeutics Announces Participation at Upcoming Scientific Conferences
November 02, 2021 07:00 ET
|
Lava Therapeutics N.V.
UTRECHT, The Netherlands and PHILADELPHIA, Nov. 02, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage biotechnology company focused on developing its proprietary...
FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE BREAST CANCER PARTNERSHIP RECEIVES NATIONAL ACCREDITATION
October 21, 2021 15:23 ET
|
Florida Cancer Specialists & Research Institute
Davenport, Fla., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute (FCS), in collaboration with AdventHealth Heart of Florida and Central Florida Cancer...